Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...

The incidence rate of RA increased globally from 1990 to 2021, with the heaviest burden born by regions with a high SDI.

Doctors explain how conditions like psoriasis, type 1 diabetes, and inflammatory bowel disease impact men, plus how these ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and damage of the joints. PET/CT imaging is a useful tool for early disease assessment and monitoring treatment ...